- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Intercept Pharmaceuticals (NASDAQ:ICPT), Quotes and News Summary
Intercept Pharmaceuticals (NASDAQ: ICPT)
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-02 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.040 | -0.250 | -0.2100 | ||||
| REV | 95.720M | 71.757M | -23.963M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Intercept Pharmaceuticals Questions & Answers
You can purchase shares of Intercept Pharmaceuticals (NASDAQ: ICPT) through any online brokerage.
Other companies in Intercept Pharmaceuticals’s space includes: Centessa Pharmaceuticals (NASDAQ:CNTA), Adagio Therapeutics (NASDAQ:ADGI), Caribou Biosciences (NASDAQ:CRBU), Generation Bio (NASDAQ:GBIO) and Kodiak Sciences (NASDAQ:KOD).
The latest price target for Intercept Pharmaceuticals (NASDAQ: ICPT) was reported by HC Wainwright & Co. on Monday, August 8, 2022. The analyst firm set a price target for 16.00 expecting ICPT to fall to within 12 months (a possible -2.23% downside). 13 analyst firms have reported ratings in the last year.
The stock price for Intercept Pharmaceuticals (NASDAQ: ICPT) is $16.365 last updated Today at August 8, 2022, 5:08 PM UTC.
There are no upcoming dividends for Intercept Pharmaceuticals.
Intercept Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 2, 2022.
There is no upcoming split for Intercept Pharmaceuticals.
Intercept Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.